Topics |
Speakers |
Time |
Venue |
SUPERFICIAL VENOUS DISEASE I
|
|
14.15-15.09 |
Session 21 |
Human lymphatic glycocalyx identification
|
|
14.16 |
|
The modern phlebology: from aesthetic to advanced disease. How to do it?
|
|
14.22 |
|
Why the CHIVA procedure is not performed by most surgeons, despite the high scientific evidence of cost-efficacy
|
|
14.28 |
|
Lesson learned from a multicenter study on endothermal ablation
|
|
14.34 |
|
Saphenous vein ablation with cyanoacrylate glue: the Italian registry
|
|
14.40 |
|
One fit most technique: laser can treat all refluxes and recurrencies
|
|
14.46 |
|
Ablation of perforating veins: when and how?
|
|
14.52 |
|
Round table/Discussion
|
|
14.58-15.09 |
|
SUPERFICIAL VENOUS DISEASE II
|
|
15.10-16.04 |
Session 22 |
Venous thromboembolic risk assessment for endovenous and foam interventions
|
|
15.11 |
|
Sclerotherapy with “superfoam”: preliminary results
|
|
15.17 |
|
Long term results of MOCA for saphenous vein incompetency
|
|
15.23 |
|
Ballon Catheter Sclerotherapy in empty vein
|
|
15.29 |
|
MOCA and crossectomy in saphenous vein insufficiency
|
|
15.35 |
|
High intensity focused ultrasound (HIFU) for the treatment of truncal reflux: a potentially disruptive technology
|
|
15.41 |
|
Do we need compression after superficial ablation?
|
|
15.47 |
|
Round table/Discussion
|
|
15.53-16.04 |
|
DEEP VEIN THROMBOSIS
|
|
16.05-16.49 |
Session 23 |
Antithrombotic therapy after venous stenting: do we need RCTs?
|
|
16.06 |
|
New devices for acute deep vein thrombosis
|
|
16.12 |
|
When conservative treatment is not the best choice for Acute DVT treatment
|
|
16.18 |
|
Mechanical thrombectomy may reduce intraprocedural complications
|
|
16.24 |
|
Endovascular treatment of Deep Vein Thrombosis: the new intelligent clot removal concept
|
|
16.30 |
|
Risk factors and classification of reintervention following deep venous stenting for acute iliofemoral deep vein thrombosis
|
|
16.36 |
|
Round table/Discussion
|
|
16.42-16.49 |
|
KEYNOTE LECTURE IX
|
|
16.50-16.59 |
|
COMPRESSIVE DISEASE AND PELVIC CONGESTION SYNDROME
|
|
17.00-17.54 |
Session 24 |
How to assess illusory May-Thurner syndrome by ultrasound
|
|
17.01 |
|
Endovascular treatment of central venous obstructive disease
|
|
17.07 |
|
IVUS guidance for diagnosis and stenting of MTS
|
|
17.13 |
|
Incidence, outcome, and management of venous stent migration
|
|
17.19 |
|
Venous obstruction in PCS needs to be treated first
|
|
17.25 |
|
Pelvic vein embolization as first choice in PCS with obstruction
|
|
17.31 |
|
Pelvic Congestion Syndrome: the Italian consensus
|
|
17.37 |
|
Round table/Discussion
|
|
17.43-17.54 |
|
POST-THROMBOTIC SYNDROME
|
|
17.55-18.54 |
Session 25 |
Misconceptions regarding elastic compression for prevention of post-thrombotic changes
|
|
17.56 |
|
Deep valve reconstruction after outflow recanalization
|
|
18.02 |
|
How to improve inflow (Access PTS)
|
|
18.08 |
|
Neointima formation following venous stenting: clinical and experimental results
|
|
18.14 |
|
Complex IVC reconstruction with different stent configuration
|
|
18.20 |
|
Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein
|
|
18.26 |
|
Current evidence on deep venous recanalization following recent trials
|
|
18.32 |
|
Performance of open and closed cell laser cut nitinol stents for the treatment of chronic iliofemoral venous outflow obstruction
|
|
18.38 |
|
Round table/Discussion
|
|
18.44-18.54 |
|